Volume | 4,687 |
|
|||||
News | - | ||||||
Day High | 2.76 | Low High |
|||||
Day Low | 2.60 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
XORTX Therapeutics Inc | XRTX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
2.67 | 2.60 | 2.76 | 2.645 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
66 | 4,687 | US$ 2.62 | US$ 12,270 | - | 1.98 - 7.524 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
11:47:35 | 5 | US$ 2.6001 | USD |
XORTX Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
5.26M | 2.00M | - | 0 | -2.16M | -1.08 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
XORTX Therapeutics News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical XRTX Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 2.99 | 3.24 | 2.5101 | 2.74 | 23,775 | -0.355 | -11.87% |
1 Month | 3.65 | 3.92 | 2.5101 | 3.17 | 18,664 | -1.02 | -27.81% |
3 Months | 2.20 | 7.00 | 2.20 | 4.35 | 53,641 | 0.435 | 19.77% |
6 Months | 2.493 | 7.00 | 1.98 | 3.33 | 70,160 | 0.142 | 5.70% |
1 Year | 6.6825 | 7.524 | 1.98 | 5.26 | 488,727 | -4.05 | -60.57% |
3 Years | 31.32 | 53.01 | 1.98 | 13.82 | 460,052 | -28.69 | -91.59% |
5 Years | 31.32 | 53.01 | 1.98 | 13.82 | 460,052 | -28.69 | -91.59% |
XORTX Therapeutics Description
XORTX Therapeutics Inc is a clinical-stage biotechnology company. The company focused on developing drug therapies for orphan diseases like polycystic kidney disease, and treatment of health consequences caused by chronic high serum uric acid which include cardiovascular disease and diabetes. |